MATHES RAINER 4
4 · CISION LTD. · Filed Jan 25, 2018
Insider Transaction Report
Form 4
CISION LTD.CISN
MATHES RAINER
President, Cision Insights
Transactions
- Other
Ordinary Shares
2018-01-23+1,735,269→ 1,735,269 total
Footnotes (2)
- [F1]Doctor Rainer Mathes acquired these securities on January 23, 2018 in connection with the completion of the Share Purchase Agreement (the "SPA"), dated as of December 23, 2017, by and among Dr. Mathes and certain wholly owned subsidiaries of Cision Ltd. (the "Company") pursuant to which the Company indirectly acquired all of Dr. Mathes' interest in Prime Research Group. The SPA provides that up to EUR 2.5 million of deferred consideration amounts may be paid to Dr. Mathes in either cash or ordinary shares of the Company. Such election will be made at the sole discretion of Canyon UK Investments Ltd. ("Canyon") at the time such amounts (if any) become due. Canyon is a wholly owned subsidiary of the Company and a party to the SPA.
- [F2]Pursuant to the Share Purchase Agreement, the price of the ordinary shares issued to Dr. Mathes was derived from the average market closing price of the Company's ordinary shares for the ten trading days preceding completion under the Share Purchase Agreement, or approximately $11.608 per share.